Autoimmune Conditions and Primary CNS Lymphoma Risk
Primary central nervous system lymphoma (PCNSL) is a rare (incidence rate of 0.6 cases per 100,000 person years) non-Hodgkin lymphoma (NHL) found in the brain, spinal cord, and leptomeninges.
Hematologic Cancer
HEMATOLOGIC CANCER ADVISOR
FEATURED CONTENT
-
-
Expert Q&A: Addressing the Survivorship Gap in Pediatric Hodgkin Lymphoma
Refining primary treatment and emphasizing secondary treatment can help mitigate the survivorship gap faced by many pediatric survivors of HL. -
FDA Proposal Threatens Transparency on Cancer Drug Safety and Efficacy
FDA documents have been a trove of information for researchers, leading to new insights about the safety and efficacy of a drug. An FDA proposal could end that. -
Assessing Novel Therapies in HIV-Positive Patients With Cancer
Evidence is emerging about the safety and efficacy of CAR-T therapy and CRISPR-based editing techniques in cancer patients with HIV. -
Why Cardiac Toxicity Should Not Prevent the Use of Ibrutinib for CLL or SLL
Final results of a landmark trial confirm the efficacy of ibrutinib for CLL and SLL—and while cardiovascular issues remain a concern, the benefits appear to outweigh the risks.
HEMATOLOGIC CANCER NEWS
FDA Grants Accelerated Approval to Brukinsa for Mantle Cell Lymphoma
Quality of Life With Busulfan and Fludarabine Compared With Busulfan and Cyclophosphamide
Response-Adapted Intensification in Multiple Myeloma After Suboptimal Response to Induction
Nurse Practitioner-Led Rapid Diagnosis Clinic May Reduce Time to Diagnosis in Lymphoma
Gastrointestinal Involvement May Be a Sign of Waldenström Macroglobulinemia
Want to read more?
Please login or register first to view this content.
Next post in Hematologic Cancers
